NURO logo

NeuroMetrix (NURO) Cash From Financing

Annual CFF

$2.33 M
-$1.54 M-39.82%

December 31, 2023


Summary


Performance

NURO Cash From Financing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherNUROcash flowmetrics:

Quarterly CFF

$0.00
-$2600.00-100.00%

September 30, 2024


Summary


Performance

NURO Quarterly CFF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherNUROcash flowmetrics:

TTM CFF

$3.10 M
-$1400.00-0.05%

September 30, 2024


Summary


Performance

NURO TTM CFF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherNUROcash flowmetrics:

Cash From Financing Formula

CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities

NURO Cash From Financing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-39.8%0.0%0.0%
3 y3 years-44.2%-100.0%-84.3%
5 y5 years+10000.0%-100.0%-25.7%

NURO Cash From Financing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-88.1%at low-100.0%+100.0%-85.6%+69.4%
5 y5-year-88.1%>+9999.0%-100.0%+100.0%-85.6%>+9999.0%
alltimeall time-92.7%>+9999.0%-100.0%+100.0%-90.2%+4224.6%

NeuroMetrix Cash From Financing History

DateAnnualQuarterlyTTM
Sep 2024
-
$0.00(-100.0%)
$3.10 M(-0.0%)
Jun 2024
-
$2600.00(-99.8%)
$3.10 M(-18.4%)
Mar 2024
-
$1.47 M(-9.4%)
$3.80 M(+63.3%)
Dec 2023
$2.33 M(-39.8%)
$1.62 M(>+9900.0%)
$2.33 M(-11.1%)
Sep 2023
-
$1400.00(-99.8%)
$2.61 M(+0.1%)
Jun 2023
-
$700.10 K(>+9900.0%)
$2.61 M(+36.0%)
Mar 2023
-
$0.00(-100.0%)
$1.92 M(-50.3%)
Dec 2022
$3.86 M(-80.2%)
$1.91 M(>+9900.0%)
$3.86 M(+111.3%)
Sep 2022
-
$0.00(-100.0%)
$1.83 M(-89.7%)
Jun 2022
-
$7800.00(-99.6%)
$17.71 M(-17.7%)
Mar 2022
-
$1.94 M(-1688.8%)
$21.52 M(+10.1%)
Dec 2021
$19.55 M(+369.2%)
-$122.30 K(-100.8%)
$19.55 M(-0.7%)
Sep 2021
-
$15.88 M(+316.3%)
$19.69 M(+417.4%)
Jun 2021
-
$3.82 M(<-9900.0%)
$3.81 M(+3.2%)
Mar 2021
-
-$25.80 K(-263.3%)
$3.69 M(-11.5%)
Dec 2020
$4.17 M(>+9900.0%)
$15.80 K(>+9900.0%)
$4.17 M(+0.2%)
Sep 2020
-
$0.00(-100.0%)
$4.16 M(0.0%)
Jun 2020
-
$3.70 M(+715.3%)
$4.16 M(+787.5%)
Mar 2020
-
$453.50 K(+5867.1%)
$468.60 K(+3003.3%)
Dec 2019
$15.10 K(-18.8%)
$7600.00(>+9900.0%)
$15.10 K(-10.7%)
Sep 2019
-
$0.00(-100.0%)
$16.90 K(-35.5%)
Jun 2019
-
$7500.00(>+9900.0%)
$26.20 K(+40.1%)
Mar 2019
-
$0.00(-100.0%)
$18.70 K(0.0%)
Dec 2018
$18.60 K(-99.9%)
$9400.00(+1.1%)
$18.70 K(-99.4%)
Sep 2018
-
$9300.00(>+9900.0%)
$3.35 M(-49.2%)
Jun 2018
-
$0.00(-100.0%)
$6.60 M(-48.9%)
Dec 2017
$12.91 M(+93.6%)
$3.34 M(+2.5%)
$12.91 M(+34.7%)
Sep 2017
-
$3.26 M(>+9900.0%)
$9.59 M(+53.1%)
Jun 2017
-
$10.40 K(-99.8%)
$6.26 M(-52.0%)
Mar 2017
-
$6.30 M(>+9900.0%)
$13.05 M(+95.7%)
Dec 2016
$6.67 M(-60.6%)
$16.70 K(-124.2%)
$6.67 M(-50.5%)
Sep 2016
-
-$69.00 K(-101.0%)
$13.48 M(-0.5%)
Jun 2016
-
$6.80 M(-8960.5%)
$13.54 M(-19.7%)
Mar 2016
-
-$76.70 K(-101.1%)
$16.86 M(-0.5%)
Dec 2015
$16.94 M(+113.5%)
$6.83 M(>+9900.0%)
$16.94 M(+67.3%)
Sep 2015
-
$0.00(-100.0%)
$10.12 M(+0.4%)
Jun 2015
-
$10.11 M(>+9900.0%)
$10.08 M(+27.1%)
Dec 2014
$7.93 M(+11.1%)
$13.90 K(-133.0%)
$7.93 M(-24.9%)
Sep 2014
-
-$42.10 K(-100.5%)
$10.56 M(+0.3%)
Jun 2014
-
$7.96 M(+201.3%)
$10.53 M(+47.6%)
Dec 2013
$7.14 M
$2.64 M(-3816.3%)
$7.14 M(+58.6%)
DateAnnualQuarterlyTTM
Sep 2013
-
-$71.10 K(-101.6%)
$4.50 M(-1.4%)
Jun 2013
-
$4.57 M(<-9900.0%)
$4.57 M(-6181.6%)
Mar 2013
-
-$5300.00(-184.1%)
-$75.10 K(-101.0%)
Dec 2012
$7.46 M(>+9900.0%)
$6300.00(-223.5%)
$7.46 M(-0.1%)
Sep 2012
-
-$5100.00(-92.8%)
$7.47 M(-0.0%)
Jun 2012
-
-$71.00 K(-100.9%)
$7.47 M(-1.1%)
Mar 2012
-
$7.53 M(>+9900.0%)
$7.55 M(>+9900.0%)
Dec 2011
$14.50 K(-91.4%)
$13.20 K(-512.5%)
$14.60 K(-56.2%)
Sep 2011
-
-$3200.00(-129.6%)
$33.30 K(+16.0%)
Jun 2011
-
$10.80 K(-274.2%)
$28.70 K(+170.8%)
Mar 2011
-
-$6200.00(-119.4%)
$10.60 K(-93.7%)
Dec 2010
$168.00 K(-99.0%)
$31.90 K(-509.0%)
$168.00 K(+95.1%)
Sep 2010
-
-$7800.00(+6.8%)
$86.10 K(-99.5%)
Jun 2010
-
-$7300.00(-104.8%)
$17.37 M(-0.6%)
Mar 2010
-
$151.20 K(-402.4%)
$17.47 M(+0.0%)
Dec 2009
$17.46 M(>+9900.0%)
-$50.00 K(-100.3%)
$17.46 M(-0.6%)
Sep 2009
-
$17.28 M(>+9900.0%)
$17.57 M(+6087.6%)
Jun 2009
-
$89.60 K(-38.2%)
$283.90 K(-2.5%)
Mar 2009
-
$145.10 K(+176.9%)
$291.20 K(+103.8%)
Dec 2008
$142.90 K(-48.7%)
$52.40 K(-1737.5%)
$142.90 K(-30.7%)
Sep 2008
-
-$3200.00(-103.3%)
$206.10 K(+0.4%)
Jun 2008
-
$96.90 K(-3128.1%)
$205.20 K(-20.1%)
Mar 2008
-
-$3200.00(-102.8%)
$256.70 K(-7.8%)
Dec 2007
$278.30 K(-82.3%)
$115.60 K(-2919.5%)
$278.30 K(-27.5%)
Sep 2007
-
-$4100.00(-102.8%)
$384.00 K(-44.9%)
Jun 2007
-
$148.40 K(+706.5%)
$696.80 K(-33.2%)
Mar 2007
-
$18.40 K(-91.7%)
$1.04 M(-33.8%)
Dec 2006
$1.58 M(+94.0%)
$221.30 K(-28.3%)
$1.58 M(-15.6%)
Sep 2006
-
$308.70 K(-37.5%)
$1.87 M(+12.7%)
Jun 2006
-
$494.20 K(-10.3%)
$1.66 M(+24.3%)
Mar 2006
-
$551.10 K(+7.3%)
$1.33 M(+64.1%)
Dec 2005
$812.20 K(-97.4%)
$513.50 K(+423.4%)
$812.10 K(+137.0%)
Sep 2005
-
$98.10 K(-42.4%)
$342.60 K(-98.4%)
Jun 2005
-
$170.30 K(+463.9%)
$21.58 M(+1.8%)
Mar 2005
-
$30.20 K(-31.4%)
$21.19 M(-33.1%)
Dec 2004
$31.67 M(+956.1%)
$44.00 K(-99.8%)
$31.67 M(+0.1%)
Sep 2004
-
$21.34 M(-9754.5%)
$31.63 M(+207.3%)
Jun 2004
-
-$221.00 K(-102.1%)
$10.29 M(-2.1%)
Mar 2004
-
$10.51 M
$10.51 M
Dec 2003
$3.00 M(+58.2%)
-
-
Dec 2002
$1.90 M
-
-

FAQ

  • What is NeuroMetrix annual cash flow from financing activities?
  • What is the all time high annual CFF for NeuroMetrix?
  • What is NeuroMetrix annual CFF year-on-year change?
  • What is NeuroMetrix quarterly cash flow from financing activities?
  • What is the all time high quarterly CFF for NeuroMetrix?
  • What is NeuroMetrix quarterly CFF year-on-year change?
  • What is NeuroMetrix TTM cash flow from financing activities?
  • What is the all time high TTM CFF for NeuroMetrix?
  • What is NeuroMetrix TTM CFF year-on-year change?

What is NeuroMetrix annual cash flow from financing activities?

The current annual CFF of NURO is $2.33 M

What is the all time high annual CFF for NeuroMetrix?

NeuroMetrix all-time high annual cash flow from financing activities is $31.67 M

What is NeuroMetrix annual CFF year-on-year change?

Over the past year, NURO annual cash flow from financing activities has changed by -$1.54 M (-39.82%)

What is NeuroMetrix quarterly cash flow from financing activities?

The current quarterly CFF of NURO is $0.00

What is the all time high quarterly CFF for NeuroMetrix?

NeuroMetrix all-time high quarterly cash flow from financing activities is $21.34 M

What is NeuroMetrix quarterly CFF year-on-year change?

Over the past year, NURO quarterly cash flow from financing activities has changed by $0.00 (0.00%)

What is NeuroMetrix TTM cash flow from financing activities?

The current TTM CFF of NURO is $3.10 M

What is the all time high TTM CFF for NeuroMetrix?

NeuroMetrix all-time high TTM cash flow from financing activities is $31.67 M

What is NeuroMetrix TTM CFF year-on-year change?

Over the past year, NURO TTM cash flow from financing activities has changed by $0.00 (0.00%)